Literature DB >> 17922968

Immunomodulatory effects of probiotics in different stages of life.

Esther Nova1, Julia Wärnberg, Sonia Gómez-Martínez, Ligia E Díaz, Javier Romeo, Ascensión Marcos.   

Abstract

The immunomodulatory properties of lactic acid bacteria (LAB) and foods containing them (e.g., fermented milks) is a topic currently under investigation. Individuals could potentially benefit from the inclusion of LAB in the diet at different times during the life cycle. One of the most accepted specific uses of probiotic bacteria is the prevention of atopic eczema in infants with family history of the disease who receive the probiotic bacteria early, through supplementation of the gestating mother and orally after birth. Immune enhancing effects have also been suggested to be beneficial in diarrhoea treatment, especially in children infected with rotavirus and in malnourished patients, infants and adolescents, whose capacity to produce IFN-gamma can be increased after LAB-containing yoghurt intake. Regarding young people and adults, investigations have been conducted exploring the immunomodulation by LAB in subjects under stressful situations, in the prevention of urinary tract infections in fertile women and in the treatment of allergy. However, the beneficial effects of probiotics in these conditions remain controversial and the scientific evidence provided so far is not considered to be conclusive. The elderly population has been the focus of investigations aimed at identifying the capacity of probiotics to counteract the immunosenescence process by increasing phagocytic and natural killer (NK) cell activities and to protect against infection. The mechanisms involved in the different effects attributed to LAB remain to be clarified. Moreover, considering that the immunomodulatory properties are strain-specific, defining the optimal dose of a certain bacteria or combination of bacteria strains and the duration of treatment for a desired effect in a target population group is essential in order to substantiate health claims.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17922968     DOI: 10.1017/S0007114507832983

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  17 in total

1.  Adhesion and immunomodulatory effects of Bifidobacterium lactis HN019 on intestinal epithelial cells INT-407.

Authors:  Chang Liu; Zhuo-Yang Zhang; Ke Dong; Xiao-Kui Guo
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Activation of Natural Killer Cells by Probiotics.

Authors:  Nabil Aziz; Benjamin Bonavida
Journal:  For Immunopathol Dis Therap       Date:  2016

3.  Probiotic manipulation of the gastrointestinal microbiota.

Authors:  Marcus Rauch; Susan V Lynch
Journal:  Gut Microbes       Date:  2010-07-27

Review 4.  Gut microbiome and aging nexus and underlying mechanism.

Authors:  Xuan Shi; Teng Ma; Hafiz Arbab Sakandar; Bilige Menghe; Zhihong Sun
Journal:  Appl Microbiol Biotechnol       Date:  2022-07-27       Impact factor: 5.560

5.  Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies.

Authors:  Mariko Wada; Satoru Nagata; Masahiro Saito; Toshiaki Shimizu; Yuichiro Yamashiro; Takahiro Matsuki; Takashi Asahara; Koji Nomoto
Journal:  Support Care Cancer       Date:  2009-08-14       Impact factor: 3.603

Review 6.  Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods.

Authors:  Delphine M A Saulnier; Jennifer K Spinler; Glenn R Gibson; James Versalovic
Journal:  Curr Opin Biotechnol       Date:  2009-02-24       Impact factor: 9.740

7.  The potential role of probiotics in the management of childhood autism spectrum disorders.

Authors:  J William Critchfield; Saskia van Hemert; Michael Ash; Linda Mulder; Paul Ashwood
Journal:  Gastroenterol Res Pract       Date:  2011-10-26       Impact factor: 2.260

Review 8.  Aging of the human metaorganism: the microbial counterpart.

Authors:  Elena Biagi; Marco Candela; Susan Fairweather-Tait; Claudio Franceschi; Patrizia Brigidi
Journal:  Age (Dordr)       Date:  2011-02-24

9.  Lactobacillus casei abundance is associated with profound shifts in the infant gut microbiome.

Authors:  Michael J Cox; Yvonne J Huang; Kei E Fujimura; Jane T Liu; Michelle McKean; Homer A Boushey; Mark R Segal; Eoin L Brodie; Michael D Cabana; Susan V Lynch
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

Review 10.  Obesity, inflammation and diet.

Authors:  Hansongyi Lee; In Seok Lee; Ryowon Choue
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2013-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.